// App-Quantinova.ai

476 2015 ATVB : Glucagon Like Peptide -1 Receptor Activation Does Not Affect Re-endothelialization But Reduces Intimal Hyperplasia via Direct Effects on Smooth Muscle Cells in a Non-diabetic Model of Arterial Injury

Researchers

Presenter

  • Robert Saxelin

Principal Investigators

  • Samuel Rohl

  • Joy Roy

  • Kenneth Caidahl

  • Thomas Nystrom

  • Ulf Hedin

  • Anton Razuvaev

Medical Centers

  • Karolinska Institutet, Stockholm, Sweden

Locations

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Intimal hyperplasia

  • Venous thrombosis

  • Restenosis

Biomarkers

  • Cyclic adenosine monophosphate

Drug/Treatment

  • Nitric oxide

  • Exenatide

  • Intranasal glucagon

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved